No price history available.
Key financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | TWDm | 215 | 195 | 384 | 206 | 281 | 253 | N/A | N/A |
| Operating profit | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | TWDm | -30 | -22 | 4 | -14 | 2 | 8 | N/A | N/A |
| EPS reported | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Established in 1988 and headquartered in Taipei, Taiwan, EBM Technologies Incorporated is dedicated to developing and commercializing sophisticated software and integrated solutions for the global healthcare sector. The company's core offerings include a comprehensive suite of Enterprise Picture Archiving and Communication Systems (PACS). This encompasses SoliPACS, designed to unify various radiology, mammography, and dental imaging products; SoliPACS Gateway for seamless DICOM communication; SoliPACS Server, acting as a crucial interface between hospital information systems (HIS), radiology information systems (RIS), and PACS; SoliPACS Web Viewer, enabling medical professionals to remotely access, compare, and utilize DICOM-compliant images; SoliPACS Report for generating customizable diagnostic reports; and the Advanced Server Archive for robust PACS data storage. EBM also leads in mobile diagnostic technology, featuring the UDE (Ubiquitous Diagnostic Environment) App, which transforms an iPad Pro into an all-in-one standalone DICOM server, viewer, display, and AI processing unit. Their extensive MobiPACS portfolio provides a complete mobile imaging ecosystem, including MobiPACS Server for storing and processing images on mobile devices, the MobiPACS App for on-the-go viewing, MobiPACS Web Viewer for accessing images from any internet-enabled device, MobiPACS Share for cloud-based collaboration, and MobiPACS Multi, which supports connecting multiple iPads/iPad Pros for integrated image display. Beyond imaging, EBM provides a range of specialized medical technologies. These include Vital-Sign On-the-Go for real-time patient monitoring; Rad@ for viewing medical-grade images and facilitating diagnoses; a Digital Pathology Scanner that converts physical slides into digital whole-slide images; the AgileRIS App for offline reporting; EPS Pi, a viewer-ready DICOM device; and the UniGate_i (UGI) App. Furthermore, the company delivers essential information management and eHealth solutions. These comprise Telemed, linking medical facilities for enhanced collaboration; Electronic Medical Records (EMR), providing digital versions of patients' medical histories; Personal Health Records (PHR), offering individuals electronic access to their health data; and broader eHealth solutions for retrieving and reviewing patient images, vital signs, and ECG waveforms.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
EBM Technologies Incorporated (8409.TWO)
No price history available.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
Established in 1988 and headquartered in Taipei, Taiwan, EBM Technologies Incorporated is dedicated to developing and commercializing sophisticated software and integrated solutions for the global healthcare sector. The company's core offerings include a comprehensive suite of Enterprise Picture Archiving and Communication Systems (PACS). This encompasses SoliPACS, designed to unify various radiology, mammography, and dental imaging products; SoliPACS Gateway for seamless DICOM communication; SoliPACS Server, acting as a crucial interface between hospital information systems (HIS), radiology information systems (RIS), and PACS; SoliPACS Web Viewer, enabling medical professionals to remotely access, compare, and utilize DICOM-compliant images; SoliPACS Report for generating customizable diagnostic reports; and the Advanced Server Archive for robust PACS data storage. EBM also leads in mobile diagnostic technology, featuring the UDE (Ubiquitous Diagnostic Environment) App, which transforms an iPad Pro into an all-in-one standalone DICOM server, viewer, display, and AI processing unit. Their extensive MobiPACS portfolio provides a complete mobile imaging ecosystem, including MobiPACS Server for storing and processing images on mobile devices, the MobiPACS App for on-the-go viewing, MobiPACS Web Viewer for accessing images from any internet-enabled device, MobiPACS Share for cloud-based collaboration, and MobiPACS Multi, which supports connecting multiple iPads/iPad Pros for integrated image display. Beyond imaging, EBM provides a range of specialized medical technologies. These include Vital-Sign On-the-Go for real-time patient monitoring; Rad@ for viewing medical-grade images and facilitating diagnoses; a Digital Pathology Scanner that converts physical slides into digital whole-slide images; the AgileRIS App for offline reporting; EPS Pi, a viewer-ready DICOM device; and the UniGate_i (UGI) App. Furthermore, the company delivers essential information management and eHealth solutions. These comprise Telemed, linking medical facilities for enhanced collaboration; Electronic Medical Records (EMR), providing digital versions of patients' medical histories; Personal Health Records (PHR), offering individuals electronic access to their health data; and broader eHealth solutions for retrieving and reviewing patient images, vital signs, and ECG waveforms.
